Welcome to Fantasy Island, where posting after the fact always makes a ton of money.
Good post. A disappointment today for sure but their business mode as you pointed out keeps the price of this stock from tanking like BLPH. It would be nice to hear more about 5010 as BLRX at some point needs revenues. You still have to hold on to the stock, more chances for stock price appreciation coming up.
Last I read was a late stage short duration pre approval trial was supposed to begin this year .BLRX still has the rights in the USA to sell. I hedged that this drug would lessen the effect of a BCM failure at least in the short term
You can still hold this stock Haven't heard any recent news about this late stage device but this is expected provide revenues soon. If you are patient BLRX still has potential
Vical couldn't look like Amgen in monopoly money. Darkouttonight is the worst biotech analyst BY FAR
Tell them to buy Vical they might not remember you lol rolmfao he he he